Joint clinical and socio-demographic determinants of CD4 cell count and body weight in HIV/TB co-infected adult patients on HAART

被引:2
|
作者
Birhan, Hailegebrael [1 ]
Seyoum, Awoke [2 ]
Derebe, Kenaw [1 ]
Muche, Setegn [1 ]
Wale, Mitiku [1 ]
Sisay, Solomon [1 ]
机构
[1] Debre Tabor Univ, Coll Nat & Computat Sci, Dept Stat, Debre Tabor, Ethiopia
[2] Bahir Dar Univ, Coll Sci, Dept Stat, Bahir Dar, Ethiopia
关键词
CD4 cell count; HIV; TB co-infection; Joint modeling; Linear mixed model; Weight; TUBERCULOSIS; SURVIVAL; TIME; PREDICTORS; HIV/AIDS; SEPARATE; AFRICA; BURDEN; MODELS;
D O I
10.1016/j.sciaf.2022.e01396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Tuberculosis is one of the most lethal communicable diseases in the world. In tuberculosis patients, HIV speeds up the course of the infection from latent to active ill-ness. This study aimed to identify joint clinical and socio demographic determinant factors of CD4+ cell count and body weight in HIV/TB co-infected adult patients.Methods: From January 2013 to December 2019, 374 HIV/TB co-infected individuals were treated and had follow-ups. This study used descriptive data analysis, a linear mixed effects model for longitudinal data, and joint modeling of the two longitudinal outcome variables.Results: In this study, 51.1% of the 374 HIV-TB co-infected patients were women, 47.1% were rural dwellers, and 71.9% developed extra pulmonary TB. Females made up 54.3% of all patients who died. To detect the presence of correlation among repeated measured data, the AR (1) structure was chosen. The joint model was more appropriate for analysing and interpreting current data.Conclusions: Baseline age, follow-up time, baseline weight, place of residence, adherence level, educational background, functional status, WHO clinical stage, smoking status and type of TB developed were identified as significant joint factors in CD4 cell count and weight of HIV/TB co-infected patients from potential joint predictor variables. Therefore, the concerned bodies, specifically the FMOH and regional health staffs, should enhance public awareness about the factors that lead to a drop in CD4 count and weight gain, as well as an increased risk of death from HIV/TB co-infection. Furthermore, special attention should be paid to women and patients with poor adherence. Medication and treatment must be affordable and accessible to all co-infected patients in order to maximize their CD4 count and proportional body weight to their height, and to lengthen the lives of indi-viduals who are co-infected. (c) 2022 The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:10
相关论文
共 50 条
  • [1] CD4 cell count recovery in HIV/TB co-infected patients versus TB uninfected HIV patients
    Wanchu, A.
    Kuttiatt, V. S.
    Sharma, A.
    Singh, S.
    Varma, S.
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (04) : 745 - 749
  • [2] Socio-demographic and clinical profile of TB/HIV-co-infected patients
    Rymanova, I.
    Nosik, M.
    Sevostyanihin, S.
    Sobkin, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 53 : 86 - 86
  • [3] Joint Modeling of Longitudinal CD4 Count and Weight Measurements of HIV/Tuberculosis Co-infected Patients at Jimma University Specialized Hospital
    Temesgen A.
    Kebede T.
    [J]. Annals of Data Science, 2016, 3 (3) : 321 - 338
  • [4] Joint Modeling of Longitudinal CD4 Count and Time-to-Death of HIV/TB Co-infected Patients: A Case of Jimma University Specialized Hospital
    Temesgen A.
    Gurmesa A.
    Getchew Y.
    [J]. Annals of Data Science, 2018, 5 (4) : 659 - 678
  • [5] Socio-Demographic, Clinical, and Mortality Differences between HIV-Infected and HIV/HTLV-1 Co-Infected Patients in Peru
    Pia Amanzo-Vargas, Maria
    Arellano-Veintemilla, Tessy
    Gonzalez-Lagos, Elsa
    Echevarria, Juan
    Mejia, Fernando
    Grana, Ana
    Gotuzzo, Eduardo
    [J]. PATHOGENS, 2023, 12 (07):
  • [6] Socio-Demographic Profile and Prevalence of Tuberculosis (TB) Treatment Outcomes among Tuberculosis/Human Immunodeficiency Virus (TB/HIV) Co-Infected Patients in Kelantan
    Nor, Siti Romaino Mohd
    Husin, Mohd Rozi
    Jaeb, Mat Zuki Mat
    Naing, Nyi Nyi
    [J]. PERTANIKA JOURNAL OF SCIENCE AND TECHNOLOGY, 2021, 29 (04): : 2279 - 2293
  • [7] Efficacy and safety of immediate versus deferred initiation of HAART in TB/HIV co-infected patients with CD4 counts <200 cells/μl
    Degu, W. A.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 5 - 5
  • [8] Long-Term CD4 Cell Count Recovery among Thai Naive HIV-Infected Patients Initiating HAART at Low CD4 Cell Count
    Chaiwarith, Romanee
    Salee, Parichart
    Kotarathitithum, Wilai
    Sirisanthana, Thira
    Supparatpinyo, Khuanchai
    [J]. CURRENT HIV RESEARCH, 2009, 7 (03) : 340 - 345
  • [9] Progression and severity of liver fibrosis in HIV-HCV co-infected patients with normal CD4 cell count: Comparison with HCV-infected patients
    Roulot, D.
    Bonilla, N.
    Barget, N.
    Andrieu, M.
    Rosenberg, A.
    Bentata, M.
    Jarrousse, B.
    Jeantils, V.
    Roudot-Thoraval, F.
    Ziol, M.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S205 - S205
  • [10] CD4+ LYMPHOCYTE COUNT IN AFRICAN PATIENTS CO-INFECTED WITH HIV AND TUBERCULOSIS
    MARTIN, DJ
    SIM, JGM
    SOLE, GJ
    RYMER, L
    SHALEKOFF, S
    VANNIEKERK, ABN
    BECKER, P
    WEILBACH, CN
    IWANIK, J
    KEDDY, K
    MILLER, GB
    OZBAY, B
    RYAN, A
    VISCOVIC, T
    WOOLF, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (04): : 386 - 391